logo

For the Inventor, By the Inventor

Halle/Saale, undefined

Scil Proteins Gmbh

Calculating rank
USPTO Granted Patents = 13

% Expired Patents = 53.8



Forward Citations = 133

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Ulrike Fiedler (7 out of 9 patents)

silverMedal Markus Fiedler (6 out of 13 patents)

bronzeMedal Rainer Rudolph (6 out of 27 patents)

4.  Erik Fiedler (5 out of 23 patents)

5.  Arnd Steuernagel (3 out of 9 patents)

6.  Adelbert Grossmann (2 out of 20 patents)

7.  Joerg Nerkamp (2 out of 2 patents)

8.  Anja Kunert (2 out of 2 patents)

9.  Anke Rattenholl (2 out of 2 patents)

10.  Elisabeth Schwarz (2 out of 4 patents)

11.  Thomas Hey (2 out of 3 patents)

12.  Michael Schraeml (1 out of 43 patents)

13.  Manja Gloser (1 out of 2 patents)

14.  Eva Bosse-Doenecke (1 out of 4 patents)

15.  Hilmar Erhard Ebersbach (1 out of 12 patents)


13 patents:

1. 9492572 - Dimeric binding proteins based on modified ubiquitins (2016-11-15),
2. 8921304 - Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin (2014-12-30),
3. 8791238 - Artificial binding proteins based on ubiquitin (2014-07-29),
4. 8790895 - Generation of artificial binding proteins on the basis of ubiquitin proteins (2014-07-29),
5. 8748351 - Method for identifying hetero-multimeric modified ubiquitin proteins with binding capability to ligands (2014-06-10),
6. 8629088 - Mixture of at least two fusion proteins, the production thereof and the use of the same (2014-01-14),
7. 8592179 - Artificial binding proteins based on a modified alpha helical region of ubiquitin (2013-11-26),
8. 8592144 - Beta-sheet proteins with specific binding properties (2013-11-26),
9. 8501439 - Method for obtaining active pro-NGF and beta-NGF (2013-08-06),
10. 8426357 - Multimeric conjugate (2013-04-23),
11. 8318671 - Pharmaceutical preparations comprising human proNGF (2012-11-27),
12. 7838629 - Ubiquitin or gamma-crystalline conjugates for use in therapy, diagnosis and chromatography (2010-11-23),
13. 7601803 - Fabrication of beta-pleated sheet proteins with specific binding properties (2009-10-13),
Company Overview
Scil Proteins GmbH specializes in the development and production of high-quality recombinant proteins and antibodies for research and therapeutic applications. The company focuses on innovative protein engineering and expression technologies, catering to the needs of the biotechnology and pharmaceutical industries. Based in Halle/Saale, Scil Proteins is committed to advancing scientific research by providing reliable and efficient solutions for protein production, enabling breakthroughs in various fields including drug development and diagnostics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#1 in Halle/Saale

#3,085 in unknown

#45,081 in the World

Halle/Saale, unknown
Halle/Saale, undefined

Scil Proteins Gmbh

Forward Citations = 133

24 inventors:

goldMedal Ulrike Fiedler (7 out of 9 patents)

silverMedal Markus Fiedler (6 out of 13 patents)

bronzeMedal Rainer Rudolph (6 out of 27 patents)

4.  Erik Fiedler (5 out of 23 patents)

5.  Arnd Steuernagel (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scil Proteins Gmbh. Retrieved from https://idiyas.com/company/scil-proteins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…